OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects
Laura Orsolini, Simone Pompili, Umberto Volpe
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5040-5040
Open Access | Times Cited: 23

Showing 23 citing articles:

Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 15

New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 9

Individual differences in associative/semantic priming: Spreading of activation in semantic memory and epistemically unwarranted beliefs
Daniel Huete‐Pérez, Robert Davies, Javier Rodríguez‐Ferreiro, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0313239-e0313239
Open Access

The Psychosis MRIShared Data Resource (Psy‐ShareD)
Paul Allen, Mariana Zurita, Rubaida Easmin, et al.
Human Brain Mapping (2025) Vol. 46, Iss. 3
Open Access

Therapeutic effects of amisulpride in male schizophrenics: Role of short-chain fatty acids and gene expression changes
Saizheng Weng, Jinchi Zheng, Yichuan Lin, et al.
Physiology & Behavior (2025), pp. 114864-114864
Closed Access

PANSS six-factor model
Elena G. Kornetova, S. А. Galkin, А. Н. Корнетов, et al.
S S Korsakov Journal of Neurology and Psychiatry (2025) Vol. 125, Iss. 2, pp. 28-28
Closed Access

Involvement of virus infections and antiviral agents in schizophrenia
Alejandro Borrego-Ruiz, Juan J. Borrego
Psychological Medicine (2025) Vol. 55
Closed Access

Schizophrenia and neuroinflammation: Pathogenetic and therapeutic aspects
A. V. Chugunov, A A Shmilovich, D. V. Nikolaeva, et al.
(2025) Vol. 27, Iss. 1, pp. 56-63
Closed Access

Revolutionizing Aripiprazole Delivery: Improving Solubility and Permeation Via Solid dispersion and In-situ Intranasal Gelling Systems
Ahmed M. Tohamey, Ibrahim S. Mousa, Fakhr-eldin S. Ghazy, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106905-106905
Closed Access

Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia
Angeliki Spathopoulou, Gabriella A Sauerwein, Valentin Marteau, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 10, pp. 3128-3140
Open Access | Times Cited: 2

Role of different omics data in the diagnosis of schizophrenia disorder: A machine learning study
Aarthy Varathan, Suntharalingam Senthooran, Pratheeba Jeyananthan
Schizophrenia Research (2024) Vol. 271, pp. 38-46
Closed Access | Times Cited: 2

Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia
Ena Španić Popovački, Dora Vogrinc, Heidi R. Fuller, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 302-302
Open Access | Times Cited: 1

Reviewing the Potential Therapeutic Approaches Targeting the Modulation of Gastrointestinal Microflora in Schizophrenia
Ilinca-Bianca Nita, Ovidiu-Dumitru Ilie, Alin Ciobîcă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16129-16129
Open Access | Times Cited: 7

The altered network complexity of resting-state functional brain activity in schizophrenia and bipolar disorder patients
Yan Niu, Nan Zhang, Mengni Zhou, et al.
Brain Science Advances (2023) Vol. 9, Iss. 2, pp. 78-94
Open Access | Times Cited: 2

Effectiveness of Recovery-Oriented cognitive therapy on Emotion Recognition and Quality of Life in Patients with Schizophrenia
Morteza Saeedi, Parviz Sharifidaramadi, Gholamreza Sharifirad
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 77-85
Open Access

Postpartum Psychosis as a Precursor to Schizophrenia: A Comprehensive Review
Rishitha Kotla, Pradeep S Patil, Isha Ahluwalia
Cureus (2024)
Open Access

Biological Characteristics of Treatment Outcomes in Schizophrenia
Manul Das, Sohini Chakraborty, Nabagata Das, et al.
Springer eBooks (2024), pp. 1-30
Closed Access

A Morphometric Examination of The Orbita Structure in Schizophrenia Patients: A Retrospective Study
Sinem Keser, Sevler Yıldız, Elif Emre
Medical Records (2024) Vol. 7, Iss. 1, pp. 195-200
Open Access

Phosphodiesterase 4 (PDE4) and neurological disorders: A promising frontier in neuropharmacology
Sumaiya Nahid, Saeedeh Saeedi, Corey R. Hopkins
Advances in pharmacology (2024), pp. 159-209
Closed Access

Enhancing Predictive Power: Integrating a Linear Support Vector Classifier with Logistic Regression for Patient Outcome Prognosis in Virtual Reality Therapy for Treatment-Resistant Schizophrenia
Alexandre Hudon, Mélissa Beaudoin, Kingsada Phraxayavong, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 12, pp. 1660-1660
Open Access | Times Cited: 1

Page 1

Scroll to top